Article

IPG with electrodic plateaus (and other unusual procedures for 2-DE).

Gruppo di Studio per la Proteomica e la Struttura delle Proteine, Dipartimento di Scienze Farmacologiche, Università degli Studi, Milano, Italia.
Electrophoresis (Impact Factor: 3.26). 09/2007; 28(16):2953-6. DOI: 10.1002/elps.200600722
Source: PubMed

ABSTRACT We describe some simple changes to the geometry of the IPG strips that make them suitable to the loading of very large sample volumes and of high-salt solutions. Of special relevance is the possibility of using strips with immobilized plateau(s) to either side of the gradient, or to both, also in connection with in-gel rehydration protocols and focusing in stock trays. The only requirement to achieve this is to leave the all-ready-made attitude and go back to custom polymerization of the IPGs in one's laboratory.

0 Bookmarks
 · 
59 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: More than a decade ago our groups pioneered the analysis of serum proteins of laboratory animals with up-to-date proteomic techniques. We were, and still are, convinced that conforming animal procedures to the minimally invasive approaches typical of clinical biochemistry focuses attention on the actual conditions under which any finding arrived at on animal models of disease may eventually be applied to human patients for screening/diagnosis. We are also convinced that, besides the proteins present in trace level as a result of tissue leakage during disorders affecting specific peripheral organs, changes in the concentration of some of the major serum proteins as part of an acute-phase response may be taken as biological end-points during a number of experimental procedures. When reviewing literature data about proteomic investigations on plasma or serum of mice, we realized that not much work has been done in the direction we favor. In addition, we noticed that sometimes information about serum proteome has been coarsely treated and in a few cases even misunderstood/misused. In the following, we present current findings on serum/plasma proteome of the laboratory mouse not only under control conditions and during an experimentally induced acute-phase reaction, but also in a number of models of disease, mainly related to cancer and to metabolic disorders.
    Proteomics 01/2012; 12(4-5):691-707. · 4.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Isoelectric focusing (IEF) in immobilized pH gradients (IPG), was first introducted in the biochemical field over six years ago. In spite of its thorough development2–5, we have the feeling that in fact IPGs are only just becoming widely known. Here we will highlight the principle of the technique and the recent developments which have improved the performance of this method.
    Trends in Biochemical Sciences 09/1988; 13(9):335–338. · 13.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this short review, we give an account of the steps through which the protocols for operation with IPGs were set up in the early '80s. One of the main achievements by our group was the development of a computer program, pH GRADIENT, for the calculation of pH, buffering power and ionic strength of a mixture of monoprotic buffers titrated within any pH span and for the linearization of the desired pH gradient. Using this program, in 1984 we could devise formulations for IPGs covering up to six pH units, which was the subject of a publication in Electrophoresis (volume 5, pages 88-97). This was the starting point for the use of IPGs for the resolution of protein samples of any composition and for their application as first dimension of 2-DE separations. Currently IPGs are in common use in proteomics investigations, not only along classical protocols but also for sample prefractionation and in shotgun approaches. Much less frequently are they used for 1-DE analytical applications, a field for which in recent years much attention has instead more often focused on capillary electrophoresis/IEF procedures.
    Electrophoresis 07/2009; 30 Suppl 1:S112-21. · 3.26 Impact Factor